Key result
Hypertension affects ~50% of middle-aged Lithuanians, with dyslipidemia co-occurring in over 92%.
Why the study?
Hypertension has a high global prevalence with frequent treatment resistance and co-occurrence of other cardiovascular risk factors, prompting investigation in middle-aged adults.
What is the prevalence of non-resistant and resistant primary arterial hypertension and associated cardiovascular risk factors in Lithuanian adults aged 50–54 years?
Cross-Sectional (n=49,155)
Yes
What is the prevalence of non-resistant and resistant primary arterial hypertension and associated cardiovascular risk factors in Lithuanian adults aged 50–54 years?
Answers are grounded in this paper and cite their sources.
Nearly half of middle-aged Lithuanians aged 50–54 years have primary arterial hypertension with suboptimal treatment and control rates and an overwhelming >90% co-prevalence of dyslipidaemia, underscoring the need for comprehensive multi-factor cardiovascular risk management.
Background: Hypertension is one of the most common cardiovascular risk factors worldwide. Additionally, epidemiological studies show a worryingly high prevalence of treatment-resistant hypertension. Especially concerning is the frequent co-occurrence of other cardiovascular risk factors, including dyslipidaemia, smoking, and diabetes mellitus. Objectives: The aim of this study is to investigate the prevalence of arterial hypertension and other cardiovascular risk factors in patients aged 50–54 years. Methods: A retrospective study was conducted on patients participating in the Lithuanian High Cardiovascular Risk Primary Prevention Programme. Data were collected from self-report questionnaires, laboratory tests, and clinical assessment. Hypertension was confirmed if systolic blood pressure was ≥140 mmHg and/or diastolic blood pressure was ≥90 mmHg or the patient had been previously diagnosed. Results: In total, 49155 patients—32018 (62.4%) women and 17137 (37.6%) men—were enrolled in this study. A total of 24549 (49.9%) patients were diagnosed with arterial hypertension. The prevalence of non-resistant primary hypertension was 45.9%, while the prevalence of resistant primary hypertension was 4.1%. The prevalence of dyslipidaemia was 92.79% in the non-resistant primary arterial hypertension group and was 94.59% in the resistant primary arterial hypertension group. The prevalence of smoking was higher in the non-resistant primary arterial hypertension group compared to patients with resistant hypertension (22.43% and 17.09%, respectively). A total of 23.06% of patients with resistant primary arterial hypertension had diabetes mellitus. Conclusions: The prevalence of primary arterial hypertension in middle-aged Lithuanians was high, reaching almost 50% in both sexes. Patients tended to have many cardiovascular risk factors simultaneously, with dyslipidaemia being the most common (prevalence > 90%).
No takes yet. Share an insight, caveat, or question.
Šileikienė et al. (2025) conducted a cross-sectional in Arterial hypertension and cardiovascular risk factors (n=49,155). Resistant primary arterial hypertension vs. Non-resistant primary arterial hypertension was evaluated on Prevalence of arterial hypertension (overall, non-resistant, and resistant) and co-occurring cardiovascular risk factors. Primary arterial hypertension affected 49.9% of Lithuanians aged 50–54 years, with dyslipidaemia co-occurring in >92% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: